ArticleClinical research in cardiology : official journal of the German Cardiac Society2025

Fibrin clot strength is associated with increased risk of major adverse cardiac events after TAVR.

David Hesselbarth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.